Related Experiment Video
Updated: Sep 10, 2025
Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
MiRNA-loaded MSC exosomes restore autophagy flux for acute pancreatitis therapy
Haojie Zeng1,2,3, Tonghua Wu1,2,3, Si Luo1,2,3
1The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong, China.
Abstract:
Acute pancreatitis (AP) is an unpredictable and potentially fatal disease. Currently, it is believed that the pathological mechanism of AP is closely related to autophagy imbalance, abnormal activation of inflammatory signals, and impairments in cell damage repair. Autophagy exhibits a double-edged sword effect of "activation accompanied by flux impairment" in AP. In this article, a systematic review is conducted on how mesenchymal stem cells (MSCs) and their secreted exosomes deliver functional miRNAs, targeting and regulating pathways such as PI3K/AKT/mTOR to achieve multiple effects including anti-inflammation, regeneration promotion, and restoration of autophagy homeostasis, providing new strategies for AP treatment. Current research challenges focus on the standardization of exosome preparation, optimization of miRNA delivery efficiency, and long-term safety evaluation. Further elucidation of the "cell-vesicle-miRNA-target pathway" cascade network, combined with multi-omics technology to develop precise intervention programs, is needed to advance AP treatment from mechanistic exploration to clinical translation.
Insights
Mesenchymal stem cells (MSCs) and their exosomes show promise for treating acute pancreatitis (AP) by delivering microRNAs to regulate inflammation and restore cell function. Further research is needed to optimize delivery and ensure safety for clinical application.
Area of Science:
- Biomedical Science
- Cell Biology
- Regenerative Medicine
Background:
- Acute pancreatitis (AP) is a severe condition linked to autophagy imbalance and inflammation.
- Autophagy's role in AP is complex, acting as a double-edged sword.
- Current treatments for AP lack targeted mechanisms for cellular repair and homeostasis.
Purpose of the Study:
- To review the therapeutic potential of mesenchymal stem cells (MSCs) and their exosomes in treating AP.
- To explore how MSC-derived exosomes deliver microRNAs (miRNAs) to modulate key signaling pathways.
- To identify strategies for improving AP treatment through exosome-based therapies.
Main Methods:
- Systematic review of existing literature on MSCs, exosomes, and miRNAs in AP.
- Analysis of miRNA targeting of pathways like PI3K/AKT/mTOR.
- Evaluation of exosome-mediated effects on inflammation, regeneration, and autophagy.
Main Results:
- MSC-derived exosomes deliver functional miRNAs that can target pathways like PI3K/AKT/mTOR.
- These miRNAs contribute to anti-inflammatory effects, promote tissue regeneration, and restore autophagy homeostasis.
- Exosomes offer a potential strategy for modulating AP pathology.
Conclusions:
- MSC-derived exosomes represent a promising therapeutic avenue for acute pancreatitis.
- Further research is required to standardize exosome preparation and optimize miRNA delivery efficiency.
- Addressing challenges in safety evaluation and understanding the intricate "cell-vesicle-miRNA-target pathway" is crucial for clinical translation.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
